๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Low-dose oral methotrexate in refractory inflammatory bowel disease

โœ Scribed by Todd H. Baron; Christopher D. Truss; Charles O. Elson

Book ID
112508936
Publisher
Springer US
Year
1993
Tongue
English
Weight
575 KB
Volume
38
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Medium-term results of oral tacrolimus t
Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease
โœ Siew C. Ng; Naila Arebi; Michael A. Kamm ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 86 KB ๐Ÿ‘ 2 views

## Background: This study aimed to evaluate the efficacy of oral tacrolimus in patients with inflammatory bowel disease (ibd) refractory to conventional therapy, including azathioprine, 6-mercaptopurine, and infliximab. ## Methods: Retrospective review of all patients with ibd treated with oral t

Plasma and rectal adenosine in inflammat
Plasma and rectal adenosine in inflammatory bowel disease: Effect of methotrexate
โœ Laurence J. Egan; Dr. William J. Sandborn; Dennis C. Mays; William J. Tremaine; ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 687 KB

In animal models, the antiinflammatory mechanism of action of methotrexate has been attributed to elevation of the extracellular concentration of the endogenous autocoid, adenosine. Our goal was to determine if methotrexate elevates adenosine concentrations in plasma and at the site of disease in pa